C&EN5h
Fuse Vectors gets $5.2 million for gene therapy tech
Danish start-up Fuse Vectors has received $5.2 million in preseed financing to further develop their gene therapy technology.
Genetic analysis links immune cell profiles to kidney cancer therapy outcomes
A comprehensive study of effective responses as well as resistant responses to a kidney cancer anti-PD-1 therapy found ...
hemophilianewstoday7h
What’s next after Pfizer’s gene therapy for hemophilia B is halted?
Columnist Jennifer Lynne assesses the effects of Pfizer's decision to halt production of its hemophilia B gene therapy, Beqvez.
hemophilianewstoday8h
Pfizer discontinues hemophilia B treatment Beqvez
Pfizer said it will discontinue gene therapy Beqvez (fidanacogene elaparvovec-dzkt), an approved hemophilia B treatment.
Gene therapy developed for maple syrup urine disease shows promise
A study led by UMass Chan Medical School researchers has demonstrated that a gene therapy to correct a mutation that causes ...
Gazette-Virginian18h
WOMEN’S HEALTH: The science in gene therapy
My brothers and I compare our genetic analyses and what diseases we are genetically at risk for and what conditions we ...